Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04541407
Title Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Colorado, Denver

lung non-small cell carcinoma


Osimertinib + Temozolomide

Lorlatinib + Temozolomide

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST